Evidence map›Paper›PMID 39795121›Full record

ArticleMolecules (Basel, Switzerland)2024

Radiolytic Elimination of Nabumetone from Aqueous Solution: Degradation Efficiency, and Degradants' Toxicity.

Ivana Tartaro Bujak, David Klarić, Bono Lučić, Krunoslav Bojanić, Maro Bujak, Nives Galić

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ivana Tartaro BujakRadiation Chemistry and Dosimetry Laboratory, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-1396-164X
David KlarićDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.ORCID 0000-0003-0109-6393
Bono LučićNMR Centre, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0001-7232-2007
Krunoslav BojanićLaboratory for Aquaculture Biotechnology, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-4182-4685
Maro BujakLaboratory for Aquaculture Biotechnology, Ruđer Bošković Institute, Bijenička cesta 54, 10000 Zagreb, Croatia.
Nives GalićDepartment of Chemistry, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.ORCID 0000-0002-0958-1791

Funding

Croatian Science Foundation IP-2022-10-6033
6 · The paper itself

Abstract

Advanced oxidation processes (AOPs), including ionizing radiation treatment, are increasingly recognized as an effective method for the degradation of pharmaceutical pollutants, including non-steroidal anti-inflammatory drugs (NSAIDs). Nabumetone (NAB), a widely used NSAID prodrug, poses an environmental risk due to its persistence in aquatic ecosystems and its potential toxicity to non-target organisms. In this study, the radiolytic degradation of NAB was investigated under different experimental conditions (dose rate, radical scavenging, pH, matrix effect), and the toxicity of its degradation products was evaluated. NAB was rapidly degraded at 300 Gy with prolonged irradiation. Mineralization of about 88% of NAB solutions was observed based on the evaluation of total organic carbon (TOC). The most efficient degradation of NAB occurred under N

Indexed as

Anti-Inflammatory Agents, Non-SteroidalNabumetoneWater Pollutants, ChemicalHydrogen-Ion ConcentrationOxidation-ReductionSolutionsWaterAnti-Inflammatory Agents, Non-SteroidalNabumetoneSolutionsWaterWater Pollutants, Chemicaldegradation productshigh-resolution mass spectrometryionizing radiationnabumetonetoxicity

Identifiers

PMID39795121
PMCPMC11722061

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.